AffiliationSligo General Hospital, The Mall, Co., Republic of Ireland.
Pulmonary Disease, Chronic Obstructive
Randomized Controlled Trials as Topic
MetadataShow full item record
CitationAnticholinergic treatment in airways diseases. 2009, 26 (10):908-19 Adv Ther
JournalAdvances in therapy
AbstractThe prevalence of chronic airways diseases such as chronic obstructive pulmonary disease and asthma is increasing. They lead to symptoms such as a cough and shortness of breath, partially through bronchoconstriction. Inhaled anticholinergics are one of a number of treatments designed to treat bronchoconstriction in airways disease. Both short-acting and long-acting agents are now available and this review highlights their efficacy and adverse event profile in chronic airways diseases.
- Tiotropium: a potential replacement for ipratropium in patients with COPD.
- Authors: Shukla VK
- Issue date: 2002 Jul
- Anticholinergic agents in asthma and COPD.
- Authors: Gross NJ
- Issue date: 2006 Mar 8
- [Tiotropium bromide in the treatment of chronic obstructive lung disease].
- Authors: Shmelev EI
- Issue date: 2003
- How safe are anticholinergics in patients with COPD?
- Authors: Hew MJ, Sestini P, Irving LB
- Issue date: 2009 May 4
- [Anticholinergics and their cardiovascular effects--between fear and reality].
- Authors: Mihălţan F, Ulmeanu R
- Issue date: 2010 Apr-Jun